Entheon Biomedical Corp (ENBI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in thousands)
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | |
| Cash Flows From Operating Activities | ||||
| Income taxes - deferred | 0 | -73 | -39 | 0 |
| Accounts receivable | 11 | -11 | N/A | N/A |
| Other Working Capital | 8 | -72 | 63 | 0 |
| Other Operating Activity | -121 | -66 | -92 | -2 |
| Operating Cash Flow | $-102 | $-221 | $-67 | $-2 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -85 | -411 | -163 | 0 |
| Investing Cash Flow | $-85 | $-411 | $-163 | $0 |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | N/A | 0 | 25 | 0 |
| Common Stock Issued | 0 | 1,673 | 592 | 0 |
| Other Financing Activity | 95 | -160 | -59 | 0 |
| Financing Cash Flow | $95 | $1,513 | $557 | $0 |
| Beginning Cash Position | 1,224 | 344 | 18 | 20 |
| End Cash Position | 1,132 | 1,224 | 344 | 18 |
| Net Cash Flow | $-92 | $880 | $326 | $-2 |
| Free Cash Flow | ||||
| Operating Cash Flow | -102 | -221 | -67 | -2 |
| Capital Expenditure | -85 | -411 | -163 | N/A |
| Free Cash Flow | -187 | -633 | -231 | -2 |